Diminished skeletal muscle microRNA expression with aging is associated with attenuated muscle plasticity and inhibition of IGF-1 signaling

FASEB Journal

Volumn 28, Issue 9, 2014, Pages 4133-4147

  Rivas, Donato A ^a   Lessard, Sarah J ^b   Rice, Nicholas P ^a   Lustgarten, Michael S ^a   So, Kawai ^a   Goodyear, Laurie J ^b   Parnell, Laurence D ^a   Fielding, Roger A ^a  

^a TUFTS UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Genomics; Humans; Noncoding RNA; Resistance exercise

Indexed keywords

INSULIN GROWTH FACTOR 1; MESSENGER RNA; MICRORNA; MICRORNA 126; SOMATOMEDIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MUSCLE CELL; MUSCLE PLASTICITY; PLASTICITY; PROTEIN EXPRESSION; RESISTANCE TRAINING; SARCOPENIA; SKELETAL MUSCLE; ADAPTATION; COMPARATIVE STUDY; DNA MICROARRAY; EXERCISE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MUSCLE FATIGUE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADAPTATION, PHYSIOLOGICAL; ADULT; AGED; AGING; BIOMARKERS; EXERCISE; GENE EXPRESSION PROFILING; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICRORNAS; MUSCLE FATIGUE; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84907210992     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-254490     Document Type: Article

References (68)

1. Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., Cederholm, T., Chandler, J., De Meynard, C., Donini, L., Harris, T., Kannt, A., Keime Guibert, F., Onder, G., Papanicolaou, D., Rolland, Y., Rooks, D., Sieber, C., Souhami, E., Verlaan, S., and Zamboni, M. (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249-256
2. Hwee, D. T., Baehr, L. M., Philp, A., Baar, K., and Bodine, S. C. (2014) Maintenance of muscle mass and load-induced growth in muscle RING finger 1 null mice with age. Aging Cell 13, 92-101
3. Janssen, I., Shepard, D. S., Katzmarzyk, P. T., and Roubenoff, R. (2004) The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 52, 80-85
4. Moon, S. S. (2014) Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: The Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocr. J. 61, 61-70
5. Akasaki, Y., Ouchi, N., Izumiya, Y., Bernardo, B. L., Lebrasseur, N. K., and Walsh, K. (2013) Glycolytic fast-twitch muscle fiber restoration counters adverse age-related changes in body composition and metabolism. Aging Cell 13, 80-91
6. Christensen, K., Doblhammer, G., Rau, R., and Vaupel, J. W. (2009) Ageing populations: the challenges ahead. Lancet 374, 1196-1208
7. Egan, B., and Zierath, J. R. (2013) Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 17, 162-184
8. Rivas, D. A., Morris, E. P., Haran, P. H., Pasha, E. P., Morais Mda, S., Dolnikowski, G. G., Phillips, E. M., and Fielding, R. A. (2012) Increased ceramide content and NFkappaB signaling may contribute to the attenuation of anabolic signaling after resistance exercise in aged males. J. Appl. Physiol. 113, 1727-1736
9. Durham, W. J., Casperson, S. L., Dillon, E. L., Keske, M. A., Paddon-Jones, D., Sanford, A. P., Hickner, R. C., Grady, J. J., and Sheffield-Moore, M. (2010) Age-related anabolic resistance after endurance-type exercise in healthy humans. FASEB J. 24, 4117-4127
10. Ameres, S. L., and Zamore, P. D. (2013) Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell. Biol. 14, 475-488
11. Timmons, J. A. (2011) Modulation of microRNAs during exercise and disease in human skeletal muscle. Exerc. Sport Sci. Rev. 39, 218; author reply 219
12. Nielsen, S., Scheele, C., Yfanti, C., Akerstrom, T., Nielsen, A. R., Pedersen, B. K., and Laye, M. J. (2010) Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J. Physiol. 588, 4029-4037
13. McCarthy, J. J., and Esser, K. A. (2007) MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. J. Appl. Physiol. 102, 306-313
14. Safdar, A., Abadi, A., Akhtar, M., Hettinga, B. P., and Tarnopolsky, M. A. (2009) miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice. PLoS One 4, e5610
15. Greco, S., Perfetti, A., Fasanaro, P., Cardani, R., Capogrossi, M. C., Meola, G., and Martelli, F. (2012) Deregulated microRNAs in myotonic dystrophy type 2. PLoS One 7, e39732
16. Spandidos, A., Wang, X., Wang, H., and Seed, B. (2010) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 38, D792-799
17. Kendziorski, C., Irizarry, R. A., Chen, K. S., Haag, J. D., and Gould, M. N. (2005) On the utility of pooling biological samples in microarray experiments. Proc. Natl. Acad. Sci. U. S. A. 102, 4252-4257
18. Chaillou, T., Lee, J. D., England, J. H., Esser, K. A., and McCarthy, J. J. (2013) Time course of gene expression during mouse skeletal muscle hypertrophy. J. Appl. Physiol. (1985) 115, 1065-1074
19. Fluck, M. (2006) Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli. J. Exp. Biol. 209, 2239-2248
20. Feng, H. Z., Wang, Q., Reiter, R. S., Lin, J. L., Lin, J. J., and Jin, J. P. (2013) Localization and function of Xinalpha in mouse skeletal muscle. Am. J. Physiol. Cell Physiol. 304, C1002-C1012
21. Bhatnagar, S., and Kumar, A. (2012) The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting. Curr. Mol. Med. 12, 3-13
22. Moyers, J. S., Bilan, P. J., Zhu, J., and Kahn, C. R. (1997) Rad and Rad-related GTPases interact with calmodulin and calmodulindependent protein kinase II. J. Biol. Chem. 272, 11832-11839
23. Wright, W. E., Sassoon, D. A., and Lin, V. K. (1989) Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617
24. Pardo, P. S., Mohamed, J. S., Lopez, M. A., and Boriek, A. M. (2011) Induction of Sirt1 by mechanical stretch of skeletal muscle through the early response factor EGR1 triggers an antioxidative response. J. Biol. Chem. 286, 2559-2566
25. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., Kang, H., Shaw, R. J., and Evans, R. M. (2008) AMPK and PPARdelta agonists are exercise mimetics. Cell 134, 405-415
26. Jager, S., Handschin, C., St-Pierre, J., and Spiegelman, B. M. (2007) AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. U. S. A. 104, 12017-12022
27. Perrini, S., Laviola, L., Carreira, M. C., Cignarelli, A., Natalicchio, A., and Giorgino, F. (2010) The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. J. Endocrinol. 205, 201-210
28. Keren, A., Tamir, Y., and Bengal, E. (2006) The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 252, 224-230
29. Kliewer, S. A., Goodwin, B., and Willson, T. M. (2002) The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev. 23, 687-702
30. Miossec, P., Korn, T., and Kuchroo, V. K. (2009) Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361, 888-898
31. Hawley, J. A., and Lessard, S. J. (2008) Exercise training-induced improvements in insulin action. Acta Physiol. (Oxf.) 192, 127-135
32. Hulsmans, M., and Holvoet, P. (2013) MicroRNAs as early biomarkers in obesity and related metabolic and cardiovascular diseases. Curr. Pharm. Des. 19, 5704-5717
33. Bates, D. J., Liang, R., Li, N., and Wang, E. (2009) The impact of noncoding RNA on the biochemical and molecular mechanisms of aging. Biochim. Biophys. Acta 1790, 970-979
34. Davidsen, P. K., Gallagher, I. J., Hartman, J. W., Tarnopolsky, M. A., Dela, F., Helge, J. W., Timmons, J. A., and Phillips, S. M. (2011) High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. J. Appl. Physiol. 110, 309-317
35. Wang, X. H. (2013) MicroRNA in myogenesis and muscle atrophy. Curr. Opin. Clin. Nutr. Metab. Care 16, 258-266
36. Boehm, M., and Slack, F. J. (2006) MicroRNA control of lifespan and metabolism. Cell Cycle 5, 837-840
37. Moore, K. J. (2013) microRNAs: small regulators with a big impact on lipid metabolism. J. Lipid Res. 54, 1159-1160
38. Olivieri, F., Rippo, M. R., Procopio, A. D., and Fazioli, F. (2013) Circulating inflamma-miRs in aging and age-related diseases. Front. Genet. 4, 121
39. Ryu, H. S., Park, S. Y., Ma, D., Zhang, J., and Lee, W. (2011) The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes. PLoS One 6, e17343
40. Dennis, R. A., Przybyla, B., Gurley, C., Kortebein, P. M., Simpson, P., Sullivan, D. H., and Peterson, C. A. (2008) Aging alters gene expression of growth and remodeling factors in human skeletal muscle both at rest and in response to acute resistance exercise. Physiol. Genomics 32, 393-400
41. Raue, U., Slivka, D., Jemiolo, B., Hollon, C., and Trappe, S. (2006) Myogenic gene expression at rest and after a bout of resistance exercise in young (18-30 yr) and old (80-89 yr) women. J. Appl. Physiol. 101, 53-59
42. Jozsi, A. C., Dupont-Versteegden, E. E., Taylor-Jones, J. M., Evans, W. J., Trappe, T. A., Campbell, W. W., and Peterson, C. A. (2000) Aged human muscle demonstrates an altered gene expression profile consistent with an impaired response to exercise. Mech. Ageing Dev. 120, 45-56
43. Raue, U., Trappe, T. A., Estrem, S. T., Qian, H. R., Helvering, L. M., Smith, R. C., and Trappe, S. (2012) Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults. J. Appl. Physiol. 112, 1625-1636
44. Schaap, L. A., Pluijm, S. M., Deeg, D. J., Harris, T. B., Kritchevsky, S. B., Newman, A. B., Colbert, L. H., Pahor, M., Rubin, S. M., Tylavsky, F. A., and Visser, M. (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J. Gerontol. A Biol. Sci. Med. Sci. 64, 1183-1189
45. Mikkelsen, U. R., Couppe, C., Karlsen, A., Grosset, J. F., Schjerling, P., Mackey, A. L., Klausen, H. H., Magnusson, S. P., and Kjaer, M. (2013) Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size. Mech. Ageing Dev. 134, 531-540
46. Wei, R., Yang, J., Liu, G. Q., Gao, M. J., Hou, W. F., Zhang, L., Gao, H. W., Liu, Y., Chen, G. A., and Hong, T. P. (2013) Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells. Gene 518, 246-255
47. Serna, E., Gambini, J., Borras, C., Abdelaziz, K. M., Belenguer, A., Sanchis, P., Avellana, J. A., Rodriguez-Manas, L., and Vina, J. (2012) Centenarians, but not octogenarians, up-regulate the expression of microRNAs. Sci. Rep. 2, 961
48. Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., Weber, M., Hamm, C. W., Roxe, T., Muller-Ardogan, M., Bonauer, A., Zeiher, A. M., and Dimmeler, S. (2010) Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684
49. Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., Mayr, A., Weger, S., Oberhollenzer, F., Bonora, E., Shah, A., Willeit, J., and Mayr, M. (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 107, 810-817
50. Drummond, M. J., McCarthy, J. J., Fry, C. S., Esser, K. A., and Rasmussen, B. B. (2008) Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids. Am. J. Physiol. Endocrinol. Metab. 295, E1333-E1340
51. Drummond, M. J., McCarthy, J. J., Sinha, M., Spratt, H. M., Volpi, E., Esser, K. A., and Rasmussen, B. B. (2011) Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol. Genomics 43, 595-603
52. Richardson, K., Lai, C. Q., Parnell, L. D., Lee, Y. C., and Ordovas, J. M. (2011) A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics 12, 504
53. Patel, C. J., Rehkopf, D. H., Leppert, J. T., Bortz, W. M., Cullen, M. R., Chertow, G. M., and Ioannidis, J. P. (2013) Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey. Int. J. Epidemiol. 42, 1795-810
54. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., and Tuschl, T. (2002) Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739
55. Wienholds, E., Kloosterman, W. P., Miska, E., Alvarez-Saavedra, E., Berezikov, E., de Bruijn, E., Horvitz, H. R., Kauppinen, S., and Plasterk, R. H. (2005) MicroRNA expression in zebrafish embryonic development. Science 309, 310-311
56. Cho, I. S., Kim, J., Seo, H. Y., Lim do, H., Hong, J. S., Park, Y. H., Park, D. C., Hong, K. C., Whang, K. Y., and Lee, Y. S. (2010) Cloning and characterization of microRNAs from porcine skeletal muscle and adipose tissue. Mol. Biol. Rep. 37, 3567-3574
57. Muroya, S., Taniguchi, M., Shibata, M., Oe, M., Ojima, K., Nakajima, I., and Chikuni, K. (2013) Profiling of differentially expressed microRNA and the bioinformatic target gene analyses in bovine fast- and slow-type muscles by massively parallel sequencing. J. Anim. Sci. 91, 90-103
58. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
59. Long, Y. C., Cheng, Z., Copps, K. D., and White, M. F. (2011) Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways. Mol. Cell. Biol. 31, 430-441
60. Kamei, Y., Miura, S., Suzuki, M., Kai, Y., Mizukami, J., Taniguchi, T., Mochida, K., Hata, T., Matsuda, J., Aburatani, H., Nishino, I., and Ezaki, O. (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 279, 41114-41123
61. Kitamura, T., Kitamura, Y. I., Funahashi, Y., Shawber, C. J., Castrillon, D. H., Kollipara, R., DePinho, R. A., Kitajewski, J., and Accili, D. (2007) A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J. Clin. Invest. 117, 2477-2485
62. Zhang, J., Du, Y. Y., Lin, Y. F., Chen, Y. T., Yang, L., Wang, H. J., and Ma, D. (2008) The cell growth suppressor, mir-126, targets IRS-1. Biochem. Biophys. Res. Commun. 377, 136-140
63. Lange, K. H., Andersen, J. L., Beyer, N., Isaksson, F., Larsson, B., Rasmussen, M. H., Juul, A., Bulow, J., and Kjaer, M. (2002) GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. J. Clin. Endocrinol. Metab. 87, 513-523
64. Alsharidah, M., Lazarus, N. R., George, T. E., Agley, C. C., Velloso, C. P., and Harridge, S. D. (2013) Primary human muscle precursor cells obtained from young and old donors produce similar proliferative, differentiation and senescent profiles in culture. Aging Cell 12, 333-344
65. Zambon, A. C., McDearmon, E. L., Salomonis, N., Vranizan, K. M., Johansen, K. L., Adey, D., Takahashi, J. S., Schambelan, M., and Conklin, B. R. (2003) Time- and exercise-dependent gene regulation in human skeletal muscle. Genome Biol. 4, R61
66. Nana-Sinkam, S. P., and Croce, C. M. (2013) Clinical applications for microRNAs in cancer. Clin. Pharmacol. Ther. 93, 98-104
67. Janssen, H. L., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A., Zhou, Y., Persson, R., King, B. D., Kauppinen, S., Levin, A. A., and Hodges, M. R. (2013) Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685-1694
68. Ling, H., Fabbri, M., and Calin, G. A. (2013) MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 12, 847-865